- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02969291
A Home-Based Study to Enhance Activity in Breast Cancer Survivors
There is a well-documented association between physical activity & risk for breast cancer development and recurrence. It is known that exercise interventions have been effective at increasing physical activity levels in breast cancer survivors. Knowing that breast cancer survivors are less active than non-cancer patients, a less active lifestyle places them at risk of obesity and poor overall health, which in turn also increases risk of cancer and cancer recurrence. Not all the reasons for the risk reduction are clear, however it is known that hormones and other inflammatory markers play a role.
This study has three goals:
- To investigate the feasibility of a home intervention designed to reduce sedentary behavior.
- Describe the effects of the intervention on levels of sedentary behavior, physical activity, and symptoms.
- Assess cost of the intervention.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
There is a well-documented association between physical activity and risk for breast cancer development and recurrence. Exercise training interventions have been effective at increasing physical activity levels in breast cancer survivors, however they require 1) a large degree of patient initiative to achieve positive health outcomes associated with sustained behavioral change and 2) facilities and oversight that may be prohibitive in a clinical setting. Although most activity-based research to date has focused on increasing levels of moderate to vigorous physical activity (MVPA) for breast cancer survivors, large epidemiological studies suggest that breast cancer survivors are also more sedentary when compared to non-cancer controls. A recent meta-analysis of controlled intervention trials designed to promote physical activity among sedentary cancer survivors found that none of the trials within the scope of the review succeeded in achieving 75% or better adherence to prescribed exercise guidelines, leading the authors to question whether shifting the target of intervention from MVPA to reductions in sedentary time might be a more realistic goal. Recent research suggests that interventions designed to reduce sedentary time in breast cancer survivors have the potential to yield clinically meaningful health benefits, especially for individuals at higher risk for sedentary behaviors, however the optimal method of intervention is not clear.
Aim 1: Feasibility of the intervention Assess the feasibility of an intervention designed to reduce sedentary behavior in breast cancer survivors. The behavioral intervention will involve the review of a 7-day baseline snapshot of sedentary behavior and physical activity patterns, combined with tailored activity prompts described over the following 6 weeks.
Aim 2: Effects of the intervention Aim 2a: Describe a preliminary range of effect sizes of the intervention on levels of sedentary behavior, physical activity and symptoms of cancer survivorship (e.g. cancer related fatigue).
Aim 2b: Evaluate the relationship between change in sedentary behavior and change in cancer-relevant outcomes, such as fatigue and biomarkers of cancer recurrence (e.g. IGF-1, Leptin), following the reduced sedentary time intervention.
Aim 3: Assessment of intervention components Aim 3a: Quantitatively assess overall cost of the intervention and its individual components, dose delivered and dose received by intervention participants Aim 3b: Quantitatively describe intervention participants' perspectives on the impact of the individual intervention components, including which components appeared most useful for reducing sedentary time.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Massachusetts
-
Springfield, Massachusetts, Forenede Stater, 01109
- Baystate Medical Center
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Stage I-III breast cancer survivors 20-80 who have completed primary treatment (surgery, radiation and/or chemotherapy) greater than 6 months but less than 5 years ago. Patients may be on adjuvant hormonal therapy
- BMI > 25 (overweight or class I/II obese)
- Not meeting current guidelines for regular exercise as defined by less than 150 minutes a week of moderate to vigorous physical activity
- No gain or loss of >10% body weight over the prior 6 months.
Exclusion Criteria:
- Known diabetes
- Known coronary artery disease
- Pregnancy
- Any injury that would limit mobility or require use of assisted mobility devices
- Weight gain or loss of >10% body weight over the prior 6 months
- Greater than 150 minutes a week of moderate to vigorous physical activity
- Inability to provide informed consent
- Non-english speaking
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Andet: Reduced Sedentary Time Intervention
Reduced Sedentary Time Intervention (RSTI)
|
Following 7 days of baseline activity monitoring a study investigator will download the information from the monitor, evaluate the periods of sedentary behavior and create a tailored RSTI for each participant.
For example, the investigator may notice a long stretch of sitting in the evening following a meal and identify several exercises that can be done indoors during that time, or if the participant is amiable to walking breaks and a period after work is identified the investigator might suggest the appropriate walking activity at that time.
This program has been successful in sedentary overweight office workers and investigators will use similar techniques.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Sedentary Time
Tidsramme: 8 weeks
|
Change in minutes/day of sedentary time as recorded by ActivPal in all 25 participants pre and post intervention.
|
8 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Activity Level
Tidsramme: 8 weeks
|
Change in Activity level as recorded by Actigraph monitor in all 25 participants
|
8 weeks
|
|
Glucose
Tidsramme: 8 weeks
|
Change in fasting glucose ( mmol/L)in all 25 participants
|
8 weeks
|
|
Insulin
Tidsramme: 8 weeks
|
Change in insulin (pmol/L) in all 25 participants
|
8 weeks
|
|
Total cholesterol
Tidsramme: 8 weeks
|
Change in total cholesterol (mmol) in all 25 participants
|
8 weeks
|
|
High density lipoprotien cholesterol
Tidsramme: 8 weeks
|
Change in high density lipoprotein cholesterol (mmol) in all 25 participants
|
8 weeks
|
|
Triglyceride
Tidsramme: 8 weeks
|
Change in triglycerides (mmol) in all 25 participants
|
8 weeks
|
|
Body Mass Index
Tidsramme: 8 weeks
|
Change in Body Mass Index (kg/m2) in all 25 participants
|
8 weeks
|
|
Waist Circumference
Tidsramme: 8 weeks
|
Change in waist circumference in cm in all 25 participants
|
8 weeks
|
|
Systolic Blood pressure
Tidsramme: 8 weeks
|
Change in systolic blood pressure measured in mmHg in all 25 participants
|
8 weeks
|
|
Diastolic Blood pressure
Tidsramme: 8 weeks
|
Change in diastolic blood pressure measured in mmHg in all 25 participants
|
8 weeks
|
|
Cancer-related fatigue measured by change in PROMIS short form 8a in all 25 participants
Tidsramme: 8 weeks
|
8 weeks
|
|
|
Cancer-related fatigue as measured by change in Visual Analog scale in all 25 participants
Tidsramme: 8 weeks
|
8 weeks
|
|
|
Sedentary behavior self -efficacy
Tidsramme: 8 weeks
|
Change in Sedentary Behavior Self-Efficacy Scale (modified from BARSE) in all 25 participants
|
8 weeks
|
|
Change in EORTC-QLQ-C30 scores in all 25 participants
Tidsramme: 8 weeks
|
8 weeks
|
|
|
Assessment of Intervention
Tidsramme: 8 weeks
|
Change in Assessment of Intervention questions on a scale of 1-5 in all 25 participants
|
8 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Grace Makari-Judson, MD, Baystate Medical Center
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 776553-5
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .